ESSA PHARMA INC

Share · CA29668H7085 · EPIX · A2JKQ4 (XNCM)

No Price

13.10.2025 20:00

Current Prices from ESSA PHARMA INC

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	EPIX	USD	13.10.2025 20:00	0,20 USD	0,00 USD

Company Profile for ESSA PHARMA INC Share

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Get up to date insights from finAgent about ESSA PHARMA INC

Company Data

Name ESSA PHARMA INC

Company ESSA Pharma Inc.

Symbol EPIX

Website https://www.essapharma.com

Primary Exchange

NASDAQ CAPITAL MARKET

WKN A2JKQ4

ISIN CA29668H7085

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO David Ross Parkinson

Market Capitalization 85 Mio

Country Canada

Currency USD

Employees 0,0 T

Address 999 West Broadway, V5Z 1K5 Vancouver

IPO Date 2015-03-13

Stock Splits

Date	Split
25.04.2018	1:20

Ticker Symbols

Name	Symbol
NASDAQ	EPIX

More Shares

Investors who hold ESSA PHARMA INC also have the following shares in their portfolio:

STADSHYPOTEK AB (PUBL) 3.25% CVRD NTS 03/11/2026 Bond

VANECK CIRC.ECON. ADLA ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog